{ "module": "kr-companies", "itemId": "00927558", "title": "EuBiologics Co., Ltd. ((주)유바이오로직스) — KOSDAQ 206650", "summary": "Korean listed company ((주)유바이오로직스, KOSDAQ 206650). Official DART corporate profile, financial summary as filed, and recent filings.", "data": { "corp_code": "00927558", "stock_code": "206650", "name_en": "EuBiologics Co., Ltd.", "name_ko": "(주)유바이오로직스", "alternate_names": [ "유바이오로직스" ], "market": "KOSDAQ", "ceo_name": "백영옥,허태영(공동대표이사)", "business_registration_no": "2118840314", "corporate_registration_no": "1101114294122", "address": "서울특별시 강남구 도산대로 509 에스디바이오센서빌딩 13층, 14층, 15층", "homepage": "https://www.eubiologics.com/", "established_date": "2010-03-10", "fiscal_month": "12", "industry_code": "212", "financials": { "fiscal_year": 2025, "basis": "OFS", "currency": "KRW", "revenue": 149195024704, "operating_income": 60663218448, "net_income": 41264003840, "total_assets": 240225281667, "total_liabilities": 64868557569, "total_equity": 175356724098, "prior_year": { "fiscal_year": 2024, "revenue": 96035297831, "operating_income": 34321335803, "net_income": 18991722463, "total_assets": 202084808067, "total_liabilities": 70052296606, "total_equity": 132032511461 }, "source_url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260317000832", "verified_at": "2026-11-08T02:22:27.640Z" }, "recent_filings": [], "source_urls": { "company": "https://dart.fss.or.kr", "financials": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260317000832", "filings": "https://dart.fss.or.kr" }, "source_url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260317000832", "verified_at": "2026-11-01T04:28:27.394Z", "notice": "Data from Korea's Financial Supervisory Service (OpenDART). FSS does not guarantee accuracy or completeness. Figures as filed, in the currency shown (usually KRW). Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.", "procurement": { "period": { "from": "2025-11-08", "to": "2026-11-07", "basis": "original_signed_date" }, "contract_count": 1, "joint_contract_count": 0, "total_amount_krw": 997000000, "by_category": { "goods": { "contract_count": 0, "amount_krw": 0 }, "construction": { "contract_count": 0, "amount_krw": 0 }, "services": { "contract_count": 1, "amount_krw": 997000000 }, "foreign": { "contract_count": 0, "amount_krw": 0 } }, "by_contract_type": { "lump_sum": { "contract_count": 1, "amount_total_krw": 997000000, "amount_this_krw": 997000000, "share_amount_krw": 997000000 }, "unit_price": { "contract_count": 0, "amount_total_krw": 0, "amount_this_krw": 0, "share_amount_krw": 0 }, "multi_year": { "contract_count": 0, "amount_total_krw": 0, "amount_this_krw": 0, "share_amount_krw": 0 }, "unknown": { "contract_count": 0, "amount_total_krw": 0, "amount_this_krw": 0, "share_amount_krw": 0 } }, "top_buyers": [ { "buyer_code": "1790399", "buyer_ko": "질병관리청 국립보건연구원", "contract_count": 1, "amount_krw": 997000000 } ], "recent_contracts": [ { "contract_no": "R26TA01788632", "title_ko": "[학술] 니파바이러스 재조합 단백질 백신 후보물질 생산 세포주 특성 분석 및 GMP 생산", "category": "services", "contract_type": "lump_sum", "signed_date": "2026-04-24", "changed_date": null, "amount_total_krw": 997000000, "amount_this_krw": 997000000, "amount_krw": 997000000, "buyer_ko": "질병관리청 국립보건연구원", "method_ko": "수의계약", "role": "주계약업체", "joint": false, "share_pct": 100, "url": "https://www.g2b.go.kr/link/FIUA027_01/single/?ctrtNo=R26TA01788632&ctrtChgOrd=00&prcmBsneSeCd=%EC%A1%B0070002&srchName=ctrtCrst&openUrl=Y" } ], "amount_note": "The 12-month window is by original contract signing date: it covers contracts first signed in the period, and excludes amendments registered in the period to contracts signed earlier. Amounts are in KRW from Korea's Public Procurement Service (KONEPS). The 12-month total counts sole contracts in full and joint contracts by the supplier's share; joint contracts without a published share are counted but not summed. Multi-year contracts count only the current-period amount. Unit-price (framework) contracts are reported separately because their values are ceilings, not spend. Where KONEPS reports no total contract amount, the current-period amount is used as the total.", "source_url": "https://www.g2b.go.kr", "verified_at": "2026-11-08T02:50:44.373Z" } }, "source_url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260317000832", "verified_at": "2026-11-01T04:28:27.394Z", "updated_at": "2026-11-08T02:50:44.373Z", "notice": "Data from Korea's Financial Supervisory Service (OpenDART). FSS does not guarantee accuracy or completeness. Figures as filed, in the currency shown (usually KRW). Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.", "amount_note": "The 12-month window is by original contract signing date: it covers contracts first signed in the period, and excludes amendments registered in the period to contracts signed earlier. Amounts are in KRW from Korea's Public Procurement Service (KONEPS). The 12-month total counts sole contracts in full and joint contracts by the supplier's share; joint contracts without a published share are counted but not summed. Multi-year contracts count only the current-period amount. Unit-price (framework) contracts are reported separately because their values are ceilings, not spend. Where KONEPS reports no total contract amount, the current-period amount is used as the total." }